Articles
 

Is Acetaminophen Use Associated with Atopic Eczema and other Allergic Diseases in Adolescents?

Abstract

Atopic Eczema (AE) is a chronic inflammatory skin disease that affects children and adults, and  alters  quality  of  life.  Previous  studies  have suggested several  socio-demographic   and environmental factors related to the prevalence of AE and other allergic diseases,  including acetaminophen use. In the present study, we report the rates of isolated AE, AE associated with asthma and AE associated with rhinitis among 13- to 14-year-old Spanish adolescents and the level of association of these conditions with the use of acetaminophen. We analyzed Spanish data from a cross-sectional Phase 3 study within ISAAC. A total of 28,717 adolescents completed the Phase 3 written questionnaire by answering questions for acetaminophen use and on asthma, rhinitis and AE symptoms.
We observed an association between acetaminophen use and AE among the adolescents who had used acetaminophen in the previous month. Furthermore, the prevalence rate increased with the number of allergic processes: for AE alone, the adjusted Prevalence Ratio (aPR) was 1.81 and for AE associated with rhinitis or with asthma, aPRs were 2.20 and 3.03, respectively.
We conclude that acetaminophen use in childhood  may be an important factor associated with development and/or maintenance of AE and other allergic diseases.

1. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International study of asthma and allergies in childhood (ISAAC): rational and methods. Eur Respir J 1995; 8(3):483–91.
2. Wieringa MH, Weyler JJ, Van Bever HP, Nelen VJ, Vermeire PA. Gender differences in respiratory, nasal and skin symptoms: 6–7 versus 13–14-year-old children. Acta Paediatr 1999; 88(2):147–9.
3. Mai X-M, Nilsson L, Braback L, Sandin A, Kjellman NIM, Bjorksten B. High body mass index, asthma and allergy in Swedish schoolchildren participating in the International Study of Asthma and Allergies in Childhood: phase II. Acta Paediatr 2003; 92(10):1144–8.
4. Sole´ D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC, Naspitz CK, Brazilian ISAAC’s Group. Is the prevalence of asthma and related symptoms among Brazilian children related to socioeconomic status? J Asthma 2008;45(1):19–25.
5. Migliore E, Pearce N, Bugiani M, Galletti G, Biggeri A, Bisanti L, et al. Prevalence of respiratory symptoms in migrant children to Italy: the results of SIDRIA-2 study. Allergy 2007; 62(3):293–300.
6. Vlaski E, Stavric K, Seckova L, Kimovska M, Isjanovska R. Influence of physical activity and televisionwatching time on asthma and allergic rhinitis among young adolescents: preventive or aggravating? Allergol Immunopathol 2008; 36(5):247–53.
7. Beasley R, Clayton T, Crane J, von Mutius E, Lai CK, Montefort S, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372(9643):1039–48.
8. Behrens T, Taeger D, Maziak W, Duhme H, Rzehak P, Weiland SK, et al. Self-reported traffic density and atopic disease in children. Results of the ISAAC Phase III survey in Muenster, Germany. Pediatr Allergy Immunol 2004; 15(4):331–9.
9. Mitchell EA, Stewart AW; ISAAC Phase One Study Group. International Study of Asthma and Allergy in Childhood. The ecological relationship of tobacco smoking to the prevalence of symptoms of asthma and other atopic diseases in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur J Epidemiol 2001; 17(7):667–73.
10. Prodanovic H, Raherison C, Vernejoux JM, Tunon de Lara JM, Taytard A. Does the presence of a pet at home influence the prevalence of asthma and rhinitis?. Rev Mal Respir 2002; 19(6):735–40.
11. Wong GW, Ko FW, Hui DS, Fok TF, Carr D, von Mutius E, et al. Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey. BMJ 2004; 329(7464):486.
12. Eneli I, Sadri K, Camargo C Jr, Bar RG. Acetaminophen and the risk of asthma: the epidemiologic and pathophysiologic evidence. Chest 2005; 127(2):604–12.
13. Farquhar H, Stewart A, Mitchell E, Crane J, Eyers S, Weatherall M, et al. The role of paracetamolin the pathogenesis of asthma. Clin Exp Allergy 2010; 40(1):32–41.
14. Vlaski E, Stavric K, Isjanovska R, Seckova L, Kimovska M. Acetaminophen intake and risk of asthma, hay fever and eczema in early adolescence. Iran J Allergy Asthma Immunol 2007; 6(3):143–9.
15. Shaheen SO, Newson RB, Sherriff A, Henderson AJ, Heron JE, Burney PG, et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002; 57(11):958–63.
16. Shaheen SO, Newson RB, Henderson AJ, Headley JE, Stratton FD, Jones RW, et al. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin Exp Allergy 2005;35(1):18–25.
17. Perzanowski MS, Miller RL, Ali DB, Ali D, Garfinkel RS, Chew GL, et al. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban, low income cohort. Thorax 2010; 65(2):118–23.
18. Cohet C, Cheng S, MacDonald C, Baker S, Foliaki N,Huntington J, et al. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health 2004;58(10):852–7.
19. Rebordosa C, Kogevinas M, Sorensen HT, Olsen J.Prenatal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study. Int J Epidemiol 2008; 37(3):583–90.
20. Wong GWK, Leung TF, Ma Y, Liu EKH, Yung E, Lai CKW. Symptoms of asthma and atopic disorders in preschool children: prevalence and risk factors. Clin Exp Allergy 2007; 37(2):174–9.
21. Beasley R, Clayton T, Crane J, von Mutius E, Lai CK,Montefort S, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372(9643):1039–48.
22. Shaheen SO, Sterne JAC, Songhurst CE, Burney PGJ.Frequent paracetamol use and asthma in adults. Thorax 2000; 55(4):266–70.
23. Davey G, Berhane Y, Duncan P, Aref-Adib G, Britton J, Venn A. Use of acetaminophen and the risk of self- reported allergic symptoms and skin sensitization in Butajira, Ethiopia. J Allergy Clin Immunol 2005;116(4):863–8.
24. Barr RG, Wentowski CC, Curhan GC, Somers SC, Stampfer MJ, Schwartz J, et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med 2004;169(7):836–41.
25. McKeever TM, Lewis SA, Smith HA, Burney P, Britton JR, Cassano PA. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med 2005;171(9):966–71.
26. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109(2):E20.
27. Nuttall SL, Williams J, Kendall MJ. Does paracetamol cause asthma?. J Clin Pharm Ther 2003; 28(4):251–7.
28. Wang H-Y, Pizzichini MMM, Becker AB, Duncan JM, Ferguson AC, Greene JM, et al. Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities. Pediatr Allergy Immunol 2010; 21(5):867–77.
29. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351(9111):1225–32
30. Karimi M, Mirzaei M, Ahmadieh MH. Acetaminophen use and the symptoms of asthma, allergic rhinitis and eczema in children. Iran J Allergy Asthma Immunol 2006; 5(2):63-7.
31. Lowe A, Abramson M, Dharmage S, Allen K.Paracetamol as a risk factor for allergic disorders. Lancet 2009; 373(9658):120.
32. Graham NMH, Burrell CH, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in hinovirus-infected volunteers. J Infect Dis 1990; 162(6):1277–82.
33. Johnston SL, Pattemore PK, Sanderson G, Smith S,Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995; 310(6989):1225–9.
34. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307(6910):982–6.
35. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116(3):571–7.
36. Prymula R, Siegrist C-A, Chlibek R, Zemlickova H, Vackova M, Smetana J, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009;374(9698):1339–50.
37. Morales Suárez-Varela M, García-Marcos L, Kogan MD, Llopis González A, Martínez Gimeno A, Aguinaga Ontoso I, et al. Parents’ smoking habit and prevalence of atopic eczema in 6-7 and 13-14 year- old schoolchildren in Spain. ISAAC phase III Allergol Immunopathol 2008;36(6):336-42.
38. Morfin-Maciel B, Barragan-Meijueiro Mde L, Nava- Ocampo AA. Individual and family household smoking habits as risk factors for wheezing among adolescents. Prev Med 2006; 43(2):98–100.

Files
IssueVol 12, No 2 (2013) QRcode
SectionArticles
Keywords
Acetaminophen Adolescents Asthma Atopic Eczema Rhinitis

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Suárez-Varela MM, García-Marcos L, Fernández-Espinar JF, Bercedo-Sanz A, Aguinaga-Ontoso I, González-Díaz C, Carvajal-Urueña I, Busquet-Monge RM, Arnedo-Pena A, García de Andoin N, Batlles-Garrido J, Blanco-Quirós A, López-Silvarrey Varela A, García-Hernández G, Gimeno-Clemente N, Rubio-López N, Llopis-González A. Is Acetaminophen Use Associated with Atopic Eczema and other Allergic Diseases in Adolescents?. Iran J Allergy Asthma Immunol. 1;12(2):115-123.